首页> 美国卫生研究院文献>World Journal of Gastroenterology >Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats
【2h】

Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats

机译:肝硬化大鼠中一氧化氮合酶II型肝表达的增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To determine the role and effect of nitric oxide synthase type II (NOS II) in cirrhotic rats.METHODS: Expression of NOS II mRNA was detected by real time RT-PCR. The activity of nitric oxide synthase and serum levels of NO, systemic and portal hemodynamics and degrees of cirrhosis were measured with high sensitive methods. Chinese traditional medicine tetrandrine was used to treat cirrhotic rats and to evaluate the function of NO. Double-blind method was applied during the experiment.RESULTS: The concentration of NO and the activity of NOS were increased markedly at all stages of cirrhosis, and iNOSmRNA was greatly expressed. Meanwhile the portal-venous-pressure (PVP), and portal-venous-flow (PVF) were significantly increased. NO, NOS and iNOSmRNA were positively correlated to the quantity of hepatic fibrosis. Tetrandrine significantly inhibited NO production and the expression of iNOSmRNA.CONCLUSION: Increased hepatic expression of NOS II is one of the important causes of hepatic cirrhosis and portal hypertension.
机译:目的:确定II型一氧化氮合酶(NOS II)在肝硬化大鼠中的作用和作用。方法:实时荧光定量PCR检测NOS II mRNA的表达。用高灵敏度的方法测定一氧化氮合酶的活性和血清NO水平,全身和门静脉血流动力学以及肝硬化程度。用中药粉防己碱治疗肝硬化大鼠并评估NO的功能。结果:肝硬化各阶段NO浓度和NOS活性均明显升高,iNOSmRNA大量表达。同时,门静脉压力(PVP)和门静脉流量(PVF)显着增加。 NO,NOS和iNOSmRNA与肝纤维化程度呈正相关。结论:粉防己碱能显着抑制NO的产生和iNOSmRNA的表达。结论:NOS II在肝脏中的表达升高是肝硬化和门脉高压的重要原因之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号